Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.
- Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.
- Delivering solutions for differing patient types coupled with planning and execution tools is essential to personalizing surgery.
- “Smith+Nephew’s technology platform is the only one in the market that allows for personalized planning using simulation and AI.
- When introducing personalized options to manage specific pathologies, we see increased patient satisfaction and clinical outcomes.